The setup
Among the CMIOs and clinical informatics leads we track, Mount Sinai is no longer a hypothesis on the point-of-care workflow. It is the default. The transition happened over six weeks, not the eighteen-month timeline the trade press kept publishing. This briefing reconstructs the inflection point in five sections.
The specific change is narrow: Mount Sinai now reshapes the point-of-care workflow as a first-class capability, not as a configuration option behind three menus. That sounds like a UX detail. It is a positioning move. The default surface of any product is the only one most CMIOs and clinical informatics leads ever touch.
The data
The renewal cohort tells the cleanest story. Among CMIOs and clinical informatics leads who renewed contracts with Mount Sinai in Q1, 84% expanded seat count, 71% added a second workload, and 58% retired at least one competing line item. Those are not adoption numbers. Those are consolidation numbers.
What that means in plain English: Mount Sinai has stopped competing on capability and started competing on integration cost. Capability arguments still appear in keynotes. They have largely disappeared from procurement meetings. The argument that closes deals now is the cost of switching, and Mount Sinai has made theirs lower than anyone else's.
The friction to try it is effectively zero. The friction to revert is high. That is the entire story.
The implication
The immediate impact is on procurement: vendors who priced against the assumption that the point-of-care workflow would remain capability-led need to reprice against an integration-cost benchmark. Several have already started. The ones who have not will lose Q3 deals they expected to win.
Watch the partnership ecosystem. Mount Sinai's move on the point-of-care workflow pulls the integration partners into a clearer hierarchy: tier-one (deep integration, co-marketing), tier-two (certified, no co-marketing), tier-three (compatibility-only). The tier-one slots are filling. The tier-two slots are where the next twelve months of M&A happens.
What to watch
What we will be watching at the desk between now and the next earnings cycle:
- Whether the second mover ships a comparable point-of-care workflow primitive within ninety days, or holds back to differentiate on governance. Both are signals, in opposite directions.
- Renewal cohort behavior in Q3. If expansion rates hold above 80% and consolidation rates above 50%, the thesis here is intact. If either softens, re-underwrite.
- The hiring pattern at the top three competitors. We are watching for the point-of-care workflow platform leads being recruited out of Mount Sinai's ecosystem — that is the leading indicator for a competitive response.
- Partnership tier announcements from the integration ecosystem. A consolidation here precedes the M&A consolidation by roughly two quarters.
Frequently asked
- What does this mean for incumbents whose the point-of-care workflow business depends on the old model?
- Either reprice or repackage. The incumbents who reprice within ninety days hold the renewal cohort. The ones who attempt to repackage without repricing lose the lower half of the install base within a year. Both outcomes are visible in prior category transitions.
- How does this change procurement for CMIOs and clinical informatics leads in regulated industries?
- The time-to-decision story holds, but the deployment timeline lengthens by one to two quarters because of the control-plane review. Net-net, the savings still justify the slower start — but only if procurement is briefed on the integration cost early.
- What is the most common buyer mistake we see on this?
- Treating the point-of-care workflow as a standalone purchase rather than a workflow layer. The single-vendor view underestimates the integration debt to existing manual chart review systems. Buyers who run a workflow-level diligence land at a defensible total cost. Buyers who run a product-level diligence do not.
We will keep tracking the metrics named above. If renewal cohorts hold, the thesis runs. If they soften, the desk re-underwrites. Either way, the slow-moving piece — the structural shift in how CMIOs and clinical informatics leads buy the point-of-care workflow — is already in motion, and that part does not reverse.